tv.qiagenbioinformatics.com

Learn how to use the copy number variant (CNV) detection tool in the QIAGEN CLC Genomics Workbench to examine your exome and targeted resequencing data.

Our live demo will cover:

• Using the CNV detection algorithm for exome and targeted resequencing data

• Adding the CNV detection tool to workflows

• Visualizing your results

Join us for the second edition of QIAGEN’s Bioinformatics Public Health Summit. This virtual event will focus on applications and tools for NGS data analysis in the public health laboratory setting. You’ll be hearing about analyses related to: enteric diseases, SARS-CoV-2, mpox, TB, PFAS, wastewater testing, and anti-microbial resistance from the QIAGEN team as well as guest speakers.

Who should join? Public health professionals, including lab scientists, epidemiologists, and infectious disease specialists interested in NGS data analysis.

Take the stress out of data analysis and fast-track your path to gene expression insights with our RNA-seq Analysis Portal. Go from FASTQ files to IPA’s pathway analysis insights in hours instead of days.Our portal supports analyses for 20 species using proven, published algorithms. The RNA-seq Analysis Portal is compatible with QIAseq and other major RNA library kits, so you can process FASTQ files from SRA, BaseSpace or your local repository.After processing and QC, you can push data directly to your IPA account* for biological interpretation.

Our high-quality, comprehensive databases are designed for biologists, wet lab scientists, and data scientists alike. Whether you prefer a seamless graphical user interface (GUI) or prefer the flexibility of programmatic access (APIs), our solutions make complex data analysis easy and accessible.

Explore the most effective ways to access our databases, including:

1. QIAGEN Ingenuity Pathway Analysis: Analyze responder vs. non-responder data and export genes from activated or inhibited pathways

2. OmicSoft Studio: Identify significant tumor vs. normal differentially expressed genes (DEGs) with proteomics or transcriptomics

3. Biomedical KB and Neo4j: Identify connected pathways, perform page rank analytics, remove top toxicology hits and show top remaining genes activated or inhibited by known drugs

4. OmicSoft Lands APIs: Perform gene set enrichment analysis to identify other diseases

Unlock actionable insights in your biological data by streamlining your data interpretation with IPA Interpret.

The newest feature of your trusted pathway analysis software, QIAGEN IPA, includes:

• Content powered by IPA's extensive, manually curated knowledge base and aided by AI

• Easy-to-share reports and updated visualizations to facilitate collaboration and dissemination of research findings

• Easy access from your favorite web browser, no additional software or hardware needed

Meet OmicSoft Explorer, a new feature included with your QIAGEN IPA/OmicSoft subscriptions. See how you can find ‘omics datasets to inform your next experiments or support your grant proposals.

With OmicSoft Explorer, you can:

• Search over 10,000 disease-relevant datasets for clinical, in vitro, normal tissue and more

• Reveal top differentially expressed genes from over 200,000 experiments

• Discover experiments that include your gene of interest

• Explore underlying biology through IPA Interpret

Each year, more than 134 million patients experience adverse drug events, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer, more effective drugs based on the unique genetic information of every individual?

In this webinar, learn about a game-changing solution for labs and pharmaceutical companies to rapidly and confidently translate complex pharmacogenomics (PGx) data into evidence-backed insights to inform therapeutic outcomes. QIAGEN Pharmacogenomic Insights (PGXI) is a new expert-curated knowledgebase solution that provides comprehensive access to verified and up-to-date data from multiple PGx sources, including the FDA, CPIC, DPWG, PharmVar, and PubMed. Built upon a legacy platform used to deliver more than 1.6 million PGx annotations for more than 250 clinical research laboratories, PGXI seamlessly integrates into existing or new workflows to automate the annotation of PGx data from all platforms, including NGS and arrays. Within minutes, users can retrieve a custom output of relevant information, including relevant conditions associated with queried genes of interest, relevant drug-gene associations, and curated literature evidence for alleles in question.

In this webinar, you will learn:

- How PGXI can help your lab efficiently and consistently identify medications associated with adverse effects.

- What expert-curated content sources are available in PGXI, eliminating the need to consult multiple databases and saving you significant time and money.

- How to use PGXI to seamlessly scale your PGXI workflow and stay at the cutting edge of PGx research.

Plus, if eligible, webinar attendees can try PGXI for free with an exclusive trial offer from QIAGEN. There’s an easier and faster way to translate PGx data into insights. Don’t miss this opportunity to elevate and transform your PGx program.

Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze from next generation sequencing (NGS) data to associations between gene variants and diseases, and finally to biological mechanisms of these gene variants. Combining QIAGEN CLC Genomics Workbench, QCII-T, and IPA, scientists can analyze sequencing data obtained from a variety of NGS technologies, annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence, and find biological connections in gene variants with manually curated scientific findings. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow.

In this webinar, attendees will have the opportunity to:

1. Learn how to import whole genome or exome sequencing data into QIAGEN CLC Genomics Workbench and use the ultra-fast LightSpeed Module that delivers end-to-end NGS FASTQ to VCF pipeline;

2. Explore capabilities in QCII-T which can enable scientists to accelerate discoveries from hereditary or tumor cohort analyses to find associations between gene variants and diseases;

3. Learn how to use IPA and its manually curated content among other integrated scientific evidence to uncover novel biological mechanisms underlying these gene variants.